Global Hip and Knee Orthopedic Surgical Robots Market Expecting to Reach $4.6 Billion by 2022: MRRBiz
MarketResearchReports.Biz announces the addition of a new report to its vast repository of research studies. The report is titled "Hip And Knee Orthopedic Surgical Robots: Market Shares, Strategy, And Forecasts, Worldwide, 2016 To 2022".
Albany, January 21, 2016 (Newswire.com) - The 2016 study has 145 pages, 64 tables and figures. Worldwide Hip and Knee Orthopedic Surgical Robot Markets are poised to achieve significant growth. The accuracy provided by the robot is not reproducible by the human surgeon, so ultimately all surgeons will want to perform the orthopedic implants using this technology.
Robot assisted medial knee arthroplasty: orthopedic surgical robots are poised to take knee and hip surgery quality far beyond what has previously been available. The quality of knee arthroplasty is improved with robotic capability. All the advantages of surgical robots carry into the Stryker Mako orthopedic reconstruction surgical products.. When the knee and hip surgical robots are used, patients have less bleeding, reduction of post-operative pain, fewer re-admissions to hospital and faster recovery. Robots support high-precision surgery. A clinic in Switzerland, La Source, has reported a reduction in the average days of hospitalization from 10 to 6.
Knee and hip surgical robots provide consistent reproducible precision. This capability is so significant for implant surgery that the robots are positioned to become the defacto standard of care for knee and hip surgery within five years. Any one getting a knee or hip replaced will demand attention to quality of life, to maintenance of lifestyle provided by a robot when they have a joint replacement.
As next generation systems, hip and knee robotic units provide a way to improve traditional orthopedic hip and knee replacement surgery. Total hip replacement surgery has evolved dramatically as advances in technology have brought improved surgical techniques. Surgical robots are a significany [art of that advance.
Once, the penetration achieves this 35% level, all orthopedic surgeons will demand that hospitals offer robotic orthopedic surgical capability because the outcomes are more predictable and better. If the hospital does not offer the robot, the surgeon will move to a more modern facility.
Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/524097
Knee and Hip Surgical Robots have been impacted by the reduction in insurance payments. Payment reductions have forced hospitals to start acting as businesses. The cost of delivering care has become as much a factor as providing quality care when making decisions about patient improvement in condition. Cost-cutting has been made in the supply chain. Suppliers were examined closely for quality and cost.
The number of suppliers is reduced to put pressure on the ones that remain. Those remaining are pressured to improve prices and efficiencies. Hospitals, physicians, and care providers have been financially incentivized to create accountable care organizations (ACOs). Coordinated patient care plans and value-based purchasing were rewarded. The med device buyer shifted from physicians to the ACOs and smart buying groups.
Stryker has thrived in this cost efficient environment with a surgical robot that permits faster surgeries, more cost efficient surgeries. In addition, Stryker offers an integrated system. The ability to include a Mako total knee application with Stryker Triathlon total knee system is anticipated to increase market share for Stryker. Stryker market leading Triathlon total knee system is helped in the market by the robot simply by the improved surgical technique possible. Surgical robots are proving themselves in a variety of disciplines, lending credibility to the Stryker robotic initiative.
Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site.
Hip and knee orthopedic surgical robot device markets at $84 million in 2015 are anticipated to reach $4.6 billion by 2022 as next generation robotic devices, systems, and instruments are introduced to manage surgery.
Radiology Oncology Surgical Robots Market Shares, Strategies, And Forecasts, Worldwide, 2016 To 2022: http://www.marketresearchreports.biz/analysis/507309
Cardiac And Lung Surgical Robots: Market Shares, Strategy, And Forecasts, Worldwide, 2015 To 2021: http://www.marketresearchreports.biz/analysis/488239